IWP Capital urges FedEx shareholders to back abortion — drug shipping risk report at Sept. 28 meeting

IWP Capital plans to vote for Proposal 6 at FedEx’s Sept. 28 annual meeting. Proposal seeks a board report within one year on legal, regulatory, reputational risks tied to shipping abortion drugs such as mifepristone. Co-filers cite uncertainty over potential Comstock Act enforcement as a material risk factor for the company’s distribution practices. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FedEx Corporation published the original content used to generate this news brief via (Ref. ID: DA50819) on September 18, 2026, and is solely responsible for the information contained therein. (C)